Lateral flow tests have all the hallmarks of a quality diagnostic test.
Fast-acting and versatile, they can be used at the point of care with or without a reader, meaning that they’re easy to use, require little training and are easily deployed in any location.
This extraordinary technology is an area where Mologic are continuing to make huge advances.
Speaking with Paul Davis, Co-founder and Chief Scientific Officer at Mologic, it was fascinating to hear what he had to say on the next steps for lateral flow. How could we improve this beautifully simple technology?
Featuring Synda Clements, Director of Talent Acquisition at ConcertAI.
Talent scarcity is hard to solve in the current climate, but developing a strategy of substance for attracting top-tier candidates is the ultimate way to stand out and win the right people. Here, I delve into how to do just that.
In an ever-changing industry, how can cell and gene therapy start-ups remain dynamic to new challenges to not only survive coming changes but thrive? Click to read more.